1. very strong uptrend
2. currently trading at the overbought area but expect it
to trade in that area with increasing price. it may pull back
a bit but take that as a buy opportunity
4. relative was rising and now on side way to digest recent upward momentum
| Price | 14.96 |
| Price Change Today | -$0.26 (-1.71%) |
| P&P rating | ![]() |
| Zacks Rank | 3 - HOLD |
| Open Price | $15.26 |
| Previous Close | $15.22 |
| Daily Range | $14.88 - $15.38 |
| 52-Week Range | $5.52 - $15.98 |
| Volume | 2,586,263 |
| Ariad Pharmaceuticals is engaged in the discovery and development of novel pharmaceuticals based on intracellular signaling technology. The Company has established highly integrated capabilities in functional genomics, molecular cell biology, structure based drug design, combinatorial chemistry and pharmacology. The company is developing small-molecule drugs that block signal transduction pathways in cells responsible for osteoporosis, and immune and inflammatory diseases. | |





2. currently trading at the overbought area but expect it
to trade in that area with increasing price. it may pull back
a bit but take that as a buy opportunity
4. relative was rising and now on side way to digest recent upward momentum
Comments: 0 | Comment
Comments: 10 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment